Copyright: ©Author(s) 2026.
World J Gastroenterol. Jul 7, 2026; 32(25): 119071
Published online Jul 7, 2026. doi: 10.3748/wjg.119071
Published online Jul 7, 2026. doi: 10.3748/wjg.119071
Table 3 Positive results of univariate and multivariate logistic regression analysis for predicting mucosal healing in Crohn’s disease
| Features | Ileal | Ileocolonic | ||||||||||
| Univariate | Multivariate | Univariate | Multivariate | |||||||||
| OR | 95%CI | P value | OR | 95%CI | P value | OR | 95%CI | P value | OR | 95%CI | P value | |
| Gender | 0.250 | 0.064-0.983 | 0.047 | 0.079 | 0.006-1.061 | 0.055 | 1.908 | 0.834-4.364 | 0.126 | |||
| Age at CD diagnosis | 1.029 | 0.989-1.071 | 0.155 | 1.009 | 0.968-1.053 | 0.662 | ||||||
| Disease duration (day) | 1.000 | 0.997-1.003 | 0.875 | 1.001 | 0.998-1.003 | 0.669 | ||||||
| CRP at baseline | 1.002 | 0.971-1.034 | 0.896 | 1.018 | 1.000-1.036 | 0.051 | 1.010 | 0.987-1.032 | 0.397 | |||
| ESR at baseline | 0.972 | 0.931-1.015 | 0.195 | 1.000 | 0.981-1.019 | 0.997 | ||||||
| WBC at baseline | 0.826 | 0.650-1.049 | 0.117 | 1.078 | 0.904-1.285 | 0.404 | ||||||
| Alb at baseline | 0.880 | 0.785-0.986 | 0.023 | 0.893 | 0.754-1.058 | 0.041 | 0.997 | 0.934-1.065 | 0.931 | |||
| FC at baseline | 0.999 | 0.998-1.000 | 0.142 | 0.999 | 0.998-1.000 | 0.015 | 0.999 | 0.998-1.001 | 0.031 | |||
| Perianal involvement | 0.443 | 0.170-1.159 | 0.095 | 0.247 | 0.051-1.187 | 0.081 | 1.352 | 0.617-2.965 | 0.451 | |||
| Smoking status at diagnosis | 1.037 | 0.214-5.016 | 0.964 | 828993669.358 | 0.000 | 1.000 | ||||||
| Previous steroids or immunomodulators use | 3.491 | 1.096-11.124 | 0.104 | 1.485 | 0.559-3.948 | 0.711 | ||||||
| Montreal behavior | 1.058 | 0.343-3.262 | 0.752 | 3.187 | 0.369-27.570 | 0.566 | ||||||
| HBI at baseline | 0.799 | 0.642-0.966 | 0.059 | 0.935 | 0.629-1.389 | 0.740 | 1.090 | 0.942-1.262 | 0.247 | |||
| Rad score | 1.173 | 1.010-1.363 | 0.037 | 3.820 | 1.541-9.473 | 0.004 | ||||||
| Pat score | 6.135 | 2.282-16.492 | < 0.001 | 3.992 | 2.198-7.250 | < 0.001 | ||||||
- Citation: Zhang H, Liu HM, Pei JX, Hu J, Zhu C, Liu KC, Rong C, Zheng XM, Shen Y, Cai YP, Wu XW. Baseline multimodal clinical-radiomics-pathomics model predicts mucosal healing in Crohn’s disease after infliximab therapy. World J Gastroenterol 2026; 32(25): 119071
- URL: https://www.wjgnet.com/1007-9327/full/v32/i25/119071.htm
- DOI: https://dx.doi.org/10.3748/wjg.119071